Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Viral | 19 | 2021 | 103 | 2.960 |
Why?
|
| Hemorrhagic Fever, Ebola | 16 | 2019 | 29 | 2.730 |
Why?
|
| Viruses | 6 | 2023 | 35 | 2.620 |
Why?
|
| Ebolavirus | 15 | 2019 | 42 | 2.530 |
Why?
|
| Phylogeny | 17 | 2020 | 612 | 1.780 |
Why?
|
| Disease Outbreaks | 13 | 2023 | 155 | 1.200 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 252 | 1.050 |
Why?
|
| Sequence Analysis, DNA | 10 | 2017 | 455 | 1.000 |
Why?
|
| Anthozoa | 3 | 2013 | 24 | 0.970 |
Why?
|
| Immunosorbents | 1 | 2022 | 1 | 0.900 |
Why?
|
| Peptide Library | 1 | 2022 | 25 | 0.890 |
Why?
|
| Onygenales | 1 | 2022 | 2 | 0.880 |
Why?
|
| Dermatomycoses | 1 | 2022 | 7 | 0.880 |
Why?
|
| Proteomics | 1 | 2022 | 302 | 0.750 |
Why?
|
| RNA, Viral | 8 | 2019 | 287 | 0.730 |
Why?
|
| Genetic Variation | 4 | 2016 | 328 | 0.700 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 63 | 0.690 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 70 | 0.690 |
Why?
|
| Communicable Disease Control | 1 | 2019 | 31 | 0.680 |
Why?
|
| Communicable Diseases | 1 | 2019 | 42 | 0.660 |
Why?
|
| Evolution, Molecular | 4 | 2020 | 249 | 0.660 |
Why?
|
| Dinoflagellida | 3 | 2014 | 8 | 0.600 |
Why?
|
| Colobus | 1 | 2016 | 1 | 0.590 |
Why?
|
| RNA Viruses | 1 | 2016 | 22 | 0.580 |
Why?
|
| Culicidae | 1 | 2016 | 21 | 0.580 |
Why?
|
| Genomics | 5 | 2019 | 201 | 0.540 |
Why?
|
| Animals | 28 | 2022 | 14307 | 0.540 |
Why?
|
| Selection, Genetic | 2 | 2017 | 42 | 0.500 |
Why?
|
| Symbiosis | 3 | 2014 | 42 | 0.500 |
Why?
|
| Orthobunyavirus | 1 | 2014 | 3 | 0.500 |
Why?
|
| Acclimatization | 2 | 2013 | 20 | 0.480 |
Why?
|
| Hot Temperature | 2 | 2014 | 120 | 0.460 |
Why?
|
| Liberia | 9 | 2019 | 13 | 0.450 |
Why?
|
| Genetic Speciation | 1 | 2012 | 9 | 0.430 |
Why?
|
| Mutation | 5 | 2024 | 1023 | 0.410 |
Why?
|
| Humans | 35 | 2024 | 34853 | 0.390 |
Why?
|
| Copepoda | 1 | 2009 | 5 | 0.360 |
Why?
|
| Genotype | 4 | 2020 | 641 | 0.340 |
Why?
|
| DNA | 2 | 2022 | 549 | 0.340 |
Why?
|
| Metagenomics | 2 | 2021 | 32 | 0.320 |
Why?
|
| Molecular Epidemiology | 5 | 2020 | 49 | 0.310 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1490 | 0.310 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 179 | 0.310 |
Why?
|
| Genetics, Population | 2 | 2022 | 66 | 0.300 |
Why?
|
| Burkholderia | 2 | 2017 | 17 | 0.290 |
Why?
|
| Sequence Analysis, RNA | 5 | 2019 | 104 | 0.290 |
Why?
|
| Cluster Analysis | 3 | 2016 | 188 | 0.280 |
Why?
|
| Burkholderia pseudomallei | 2 | 2017 | 34 | 0.280 |
Why?
|
| Viral Envelope Proteins | 2 | 2017 | 77 | 0.280 |
Why?
|
| Antibody Formation | 2 | 2022 | 73 | 0.280 |
Why?
|
| Geography | 4 | 2020 | 86 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 282 | 0.270 |
Why?
|
| Moraxella | 2 | 2015 | 2 | 0.270 |
Why?
|
| Moraxellaceae Infections | 2 | 2015 | 2 | 0.270 |
Why?
|
| Monkey Diseases | 2 | 2015 | 6 | 0.270 |
Why?
|
| Phlebovirus | 2 | 2015 | 2 | 0.260 |
Why?
|
| Semen | 4 | 2018 | 48 | 0.250 |
Why?
|
| Aedes | 3 | 2019 | 20 | 0.240 |
Why?
|
| Enterovirus D, Human | 1 | 2023 | 2 | 0.230 |
Why?
|
| Enterovirus Infections | 1 | 2023 | 4 | 0.230 |
Why?
|
| Chromosome Mapping | 1 | 2023 | 159 | 0.230 |
Why?
|
| Incidence | 3 | 2020 | 882 | 0.220 |
Why?
|
| Oligonucleotides | 1 | 2022 | 48 | 0.220 |
Why?
|
| Snakes | 1 | 2022 | 8 | 0.220 |
Why?
|
| Climate Change | 2 | 2013 | 33 | 0.220 |
Why?
|
| Antibodies | 1 | 2022 | 135 | 0.220 |
Why?
|
| Macaca mulatta | 3 | 2021 | 122 | 0.220 |
Why?
|
| Mammals | 1 | 2022 | 96 | 0.210 |
Why?
|
| Deoxyribonuclease I | 1 | 2021 | 25 | 0.210 |
Why?
|
| Proviruses | 1 | 2021 | 27 | 0.210 |
Why?
|
| Simian immunodeficiency virus | 1 | 2021 | 56 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 445 | 0.200 |
Why?
|
| Software | 2 | 2020 | 204 | 0.190 |
Why?
|
| Academies and Institutes | 2 | 2018 | 35 | 0.190 |
Why?
|
| Brucellosis, Bovine | 1 | 2020 | 2 | 0.190 |
Why?
|
| Brucella abortus | 1 | 2020 | 5 | 0.190 |
Why?
|
| Brucellosis | 1 | 2020 | 8 | 0.190 |
Why?
|
| Insect Vectors | 2 | 2017 | 21 | 0.190 |
Why?
|
| Arizona | 1 | 2020 | 92 | 0.190 |
Why?
|
| Antiviral Agents | 2 | 2019 | 148 | 0.190 |
Why?
|
| Lassa Fever | 1 | 2019 | 1 | 0.180 |
Why?
|
| Lassa virus | 1 | 2019 | 1 | 0.180 |
Why?
|
| Peptides | 1 | 2022 | 308 | 0.180 |
Why?
|
| DNA, Mitochondrial | 2 | 2012 | 165 | 0.180 |
Why?
|
| Survivors | 2 | 2018 | 126 | 0.180 |
Why?
|
| Sequence Homology | 2 | 2016 | 34 | 0.180 |
Why?
|
| Turtles | 1 | 2019 | 28 | 0.180 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 40 | 0.180 |
Why?
|
| Ebola Vaccines | 1 | 2019 | 8 | 0.170 |
Why?
|
| Viral Proteins | 1 | 2020 | 172 | 0.170 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 114 | 0.170 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2018 | 11 | 0.170 |
Why?
|
| Macaca fascicularis | 2 | 2015 | 61 | 0.170 |
Why?
|
| Plasmids | 2 | 2021 | 233 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 106 | 0.170 |
Why?
|
| Virulence Factors | 2 | 2017 | 113 | 0.160 |
Why?
|
| Arenaviruses, New World | 1 | 2017 | 1 | 0.160 |
Why?
|
| Arenaviridae Infections | 1 | 2017 | 3 | 0.160 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 10 | 0.160 |
Why?
|
| Sugar Acids | 1 | 2017 | 1 | 0.150 |
Why?
|
| Chikungunya virus | 1 | 2017 | 16 | 0.150 |
Why?
|
| Mutant Proteins | 1 | 2017 | 48 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2019 | 159 | 0.150 |
Why?
|
| Virus Internalization | 1 | 2017 | 27 | 0.150 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 72 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2017 | 80 | 0.150 |
Why?
|
| Nairovirus | 1 | 2016 | 1 | 0.150 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 78 | 0.140 |
Why?
|
| Tularemia | 1 | 2017 | 114 | 0.140 |
Why?
|
| Poly U | 1 | 2015 | 2 | 0.140 |
Why?
|
| Primates | 1 | 2016 | 36 | 0.140 |
Why?
|
| Burkholderia mallei | 1 | 2015 | 6 | 0.140 |
Why?
|
| Francisella tularensis | 1 | 2017 | 115 | 0.140 |
Why?
|
| Immunization, Passive | 1 | 2015 | 18 | 0.140 |
Why?
|
| User-Computer Interface | 1 | 2015 | 62 | 0.140 |
Why?
|
| Immune Evasion | 1 | 2015 | 16 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 240 | 0.140 |
Why?
|
| Bunyaviridae Infections | 1 | 2015 | 5 | 0.140 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2015 | 11 | 0.130 |
Why?
|
| Chemokines | 1 | 2015 | 89 | 0.130 |
Why?
|
| Macaca | 1 | 2014 | 38 | 0.130 |
Why?
|
| Fever | 1 | 2015 | 57 | 0.130 |
Why?
|
| United States | 2 | 2022 | 3894 | 0.130 |
Why?
|
| Computational Biology | 2 | 2015 | 275 | 0.120 |
Why?
|
| Phlebotomus Fever | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hybridization, Genetic | 1 | 2012 | 11 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2012 | 111 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 520 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 968 | 0.110 |
Why?
|
| Macrophages | 1 | 2015 | 431 | 0.110 |
Why?
|
| Species Specificity | 3 | 2017 | 233 | 0.100 |
Why?
|
| RNA | 1 | 2012 | 234 | 0.090 |
Why?
|
| Cytochromes b | 1 | 2009 | 6 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 2 | 2024 | 102 | 0.090 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 12 | 0.090 |
Why?
|
| Epitopes | 2 | 2022 | 145 | 0.090 |
Why?
|
| Mitochondria | 1 | 2012 | 454 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2020 | 1961 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 165 | 0.080 |
Why?
|
| Travel | 2 | 2019 | 32 | 0.080 |
Why?
|
| Brazil | 2 | 2018 | 66 | 0.080 |
Why?
|
| Female | 8 | 2018 | 19873 | 0.080 |
Why?
|
| Sierra Leone | 2 | 2019 | 3 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1300 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2009 | 351 | 0.080 |
Why?
|
| Bacterial Typing Techniques | 2 | 2017 | 34 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 89 | 0.070 |
Why?
|
| Virulence | 2 | 2017 | 221 | 0.070 |
Why?
|
| Adult | 5 | 2023 | 11034 | 0.070 |
Why?
|
| Recombination, Genetic | 2 | 2017 | 90 | 0.070 |
Why?
|
| Virus Replication | 2 | 2018 | 261 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 322 | 0.060 |
Why?
|
| Male | 6 | 2018 | 18870 | 0.060 |
Why?
|
| Unsafe Sex | 2 | 2015 | 161 | 0.060 |
Why?
|
| Cell Line | 2 | 2017 | 1289 | 0.060 |
Why?
|
| Base Sequence | 2 | 2015 | 932 | 0.060 |
Why?
|
| Stress, Physiological | 2 | 2014 | 137 | 0.050 |
Why?
|
| Endonucleases | 1 | 2021 | 18 | 0.050 |
Why?
|
| Mice | 3 | 2017 | 5668 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2021 | 87 | 0.050 |
Why?
|
| Buffaloes | 1 | 2020 | 3 | 0.050 |
Why?
|
| Costa Rica | 1 | 2020 | 7 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2020 | 29 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 259 | 0.050 |
Why?
|
| Adolescent | 2 | 2023 | 5035 | 0.050 |
Why?
|
| West Indies | 1 | 2019 | 10 | 0.050 |
Why?
|
| Mosquito Control | 1 | 2019 | 8 | 0.050 |
Why?
|
| Cuba | 1 | 2019 | 32 | 0.050 |
Why?
|
| Pacific Ocean | 1 | 2019 | 13 | 0.040 |
Why?
|
| Democratic Republic of the Congo | 1 | 2019 | 5 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2018 | 12 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2018 | 17 | 0.040 |
Why?
|
| Guinea | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 472 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2018 | 58 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 9642 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2018 | 72 | 0.040 |
Why?
|
| Virus Activation | 1 | 2018 | 35 | 0.040 |
Why?
|
| Serial Passage | 1 | 2017 | 4 | 0.040 |
Why?
|
| Vesiculovirus | 1 | 2017 | 4 | 0.040 |
Why?
|
| Virus Cultivation | 1 | 2017 | 5 | 0.040 |
Why?
|
| Culex | 1 | 2017 | 4 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2017 | 23 | 0.040 |
Why?
|
| Climate | 1 | 2017 | 14 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2017 | 15 | 0.040 |
Why?
|
| Rec A Recombinases | 1 | 2017 | 2 | 0.040 |
Why?
|
| Burkholderia Infections | 1 | 2017 | 2 | 0.040 |
Why?
|
| Northern Territory | 1 | 2017 | 2 | 0.040 |
Why?
|
| Vero Cells | 1 | 2017 | 90 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2017 | 141 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2017 | 63 | 0.040 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2017 | 8 | 0.040 |
Why?
|
| Internationality | 1 | 2017 | 29 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 87 | 0.040 |
Why?
|
| Point Mutation | 1 | 2017 | 88 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 122 | 0.040 |
Why?
|
| Melioidosis | 1 | 2017 | 21 | 0.040 |
Why?
|
| Australia | 1 | 2017 | 76 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2016 | 25 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 9 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2017 | 88 | 0.040 |
Why?
|
| Water Microbiology | 1 | 2017 | 72 | 0.040 |
Why?
|
| Nigeria | 1 | 2016 | 74 | 0.040 |
Why?
|
| Dengue Virus | 1 | 2017 | 84 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 165 | 0.040 |
Why?
|
| Linear Models | 1 | 2017 | 253 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2016 | 90 | 0.040 |
Why?
|
| Arenavirus | 1 | 2015 | 1 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 203 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2016 | 118 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 20 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 184 | 0.040 |
Why?
|
| Coronavirus | 1 | 2015 | 7 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 118 | 0.030 |
Why?
|
| Giant Cells | 1 | 2015 | 13 | 0.030 |
Why?
|
| Flavivirus | 1 | 2015 | 10 | 0.030 |
Why?
|
| Nose Diseases | 1 | 2015 | 2 | 0.030 |
Why?
|
| Coitus | 1 | 2015 | 13 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 358 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 200 | 0.030 |
Why?
|
| Psychodidae | 1 | 2015 | 3 | 0.030 |
Why?
|
| Panama | 1 | 2015 | 5 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2016 | 100 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2015 | 62 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1425 | 0.030 |
Why?
|
| Drug Resistance, Viral | 1 | 2015 | 60 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 49 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 649 | 0.030 |
Why?
|
| Actins | 1 | 2015 | 142 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2015 | 83 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 569 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 1014 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2015 | 135 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 73 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 288 | 0.030 |
Why?
|
| RNA, Protozoan | 1 | 2014 | 13 | 0.030 |
Why?
|
| Genes, Protozoan | 1 | 2014 | 18 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 650 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 204 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1318 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 485 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 605 | 0.030 |
Why?
|
| Reassortant Viruses | 1 | 2013 | 10 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2018 | 371 | 0.030 |
Why?
|
| American Samoa | 1 | 2013 | 16 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 2013 | 20 | 0.030 |
Why?
|
| Heat-Shock Response | 1 | 2013 | 19 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 435 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 1124 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 913 | 0.030 |
Why?
|
| Genome | 1 | 2013 | 117 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2333 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 260 | 0.030 |
Why?
|
| Child | 1 | 2018 | 2875 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 600 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 6448 | 0.020 |
Why?
|